Tempest Therapeutics Inc (TPST)

Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Income/Loss	81.06%-5.25	-27.72	-4.08	-3.60	-7.97
Nonoperating Income/Loss	73.91%0.01	0.02	0.06	0.09	0.10
Income Tax Expense/Benefit	-	-	-	-	-
	81.07%-5.24	-27.70	-4.02	-3.51	-7.87
Attributable To Parent	81.07%-5.24	-27.70	-4.02	-3.51	-7.87
Basic Average Shares	39.27%15.22	10.93	-	4.44	3.80
Diluted Average Shares	39.27%15.22	10.93	-	4.44	3.80
Basic Earnings Per Share	86.56%-0.34	-2.53	-	-0.79	-2.07
Diluted Earnings Per Share	86.56%-0.34	-2.53	-	-0.79	-2.07